导航癌症护理连续:对黑人和白人乳腺癌患者的比较研究
Min K Lee1, Naomi T-T Levine2, Lisa R Hayes3
1School of Industrial Engineering, Purdue University, West Lafayette, IN, United States of America.
PloS one
|October 24, 2024
概括
黑人乳腺癌患者面临更大的差异,由于障碍,如诊断延迟和沟通不良. 在患者护理中解决这些问题对于降低死亡率和实现健康公平至关重要.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 健康差异 在健康上的差异
背景情况:
- 黑人和白人乳腺癌患者之间存在显著的死亡率差异,尽管治疗方面取得了进展.
- 了解患者的体验是识别和解决这种差异的根本原因的关键.
研究的目的:
- 调查和比较乳腺癌患者的旅程和黑人和白人个人的经历.
- 确定导致乳腺癌护理医疗保健差异的具体挑战和障碍.
主要方法:
- 进行了半结构面试,以收集定性患者体验数据.
- 从医疗记录中提取了医疗服务和时间表数据.
- 应用了主题分析来绘制患者的旅程,并比较跨癌症护理连续性的经验.
主要成果:
- 两组人都面临着财务,治疗,自主和情感支持方面的挑战.
- 黑人患者遇到了额外的重大障碍:文化不一致,无效的患者-提供者沟通和延迟诊断.
- 在所有阶段都观察到差异:诊断,手术,化疗/辐射和随访护理.
结论:
- 对黑人乳腺癌患者来说,有效的患者-医疗服务提供者沟通,文化一致性和及时诊断至关重要.
- 在整个癌症护理连续过程中,增强导航和情绪支持至关重要.
- 解决这些因素可以帮助缓解医疗保健差异,并改善黑人患者的治疗结果.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Comparing the Survival Analysis of Two or More Groups
155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155
Patient-centered Care
2.0K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.0K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


